Calcium in PDB 4z89: SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide

The structure of SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide, PDB code: 4z89 was solved by J.H.Driller, N.Holton, M.Siebert, M.A.Boehme, M.C.Wahl, S.J.Sigrist, B.Loll, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	43.87 / 2.64
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	58.300, 122.220, 68.540, 90.00, 113.17, 90.00
R / Rfree (%)	25.5 / 31.2

The binding sites of Calcium atom in the SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide (pdb code 4z89). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide, PDB code: 4z89:

Calcium binding site 1 out of 1 in the SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of SH3-II of Drosophila Rim-Binding Protein Bound to A Cacophony Derived Peptide within 5.0Å range: probe atom residue distance (Å) B Occ B:Ca1401 b:46.3 occ:1.00 OD1 B:ASP1339 2.4 62.0 1.0 O A:HOH1405 2.5 49.6 1.0 O C:HOH1405 2.5 38.8 1.0 CG B:ASP1339 3.2 57.1 1.0 O A:SER1329 3.3 62.5 1.0 OD2 B:ASP1339 3.4 60.0 1.0 OG A:SER1329 3.7 33.6 1.0 CA A:SER1329 4.0 27.0 1.0 C A:SER1329 4.1 43.9 1.0 OE2 C:GLU1340 4.3 61.7 1.0 CB A:SER1329 4.3 32.3 1.0 CB B:ASP1339 4.7 46.2 1.0 CB A:CYS1338 4.7 42.0 1.0 SG A:CYS1338 4.8 36.3 1.0

M.Siebert, M.A.Bohme, J.H.Driller, H.Babikir, M.M.Mampell, U.Rey, N.Ramesh, T.Matkovic, N.Holton, S.Reddy-Alla, F.Gottfert, D.Kamin, C.Quentin, S.Klinedinst, T.F.Andlauer, S.W.Hell, C.A.Collins, M.C.Wahl, B.Loll, S.J.Sigrist. A High Affinity Rim-Binding Protein/APLIP1 Interaction Prevents the Formation of Ectopic Axonal Active Zones. Elife V. 4 2015.
ISSN: ESSN 2050-084X
PubMed: 26274777
DOI: 10.7554/ELIFE.06935